Key takeaways
Jardiance (empagliflozin) and Victoza (liraglutide) are both medications used to manage Type 2 diabetes, but they work in different ways and have different forms. Jardiance is a sodium-glucose co-transporter 2 (SGLT2) inhibitor taken as a pill once a day, while Victoza is a Glucagon-like peptide-1 (GLP-1) agonist that you inject once a day. Jardiance helps lower blood sugar by making your body get rid of extra sugar through urine and also helps with heart failure and chronic kidney disease. Victoza, on the other hand, helps your body release more insulin, stops it from releasing too much sugar, and slows down digestion. Jardiance can cause urinary tract infections and yeast infections, while Victoza can cause nausea, vomiting, and diarrhea. Jardiance is currently only available as a brand-name medication, with generics expected in 2025, whereas Victoza does not have a generic form. Both medications can help with weight loss, but neither is specifically approved for this purpose.
